bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/39405332
 
Alexander Mellmann; Chiara Robin Bojarzyn; Eike Roman Hrincius; Eva Ulla Lorentzen; Georg Lenz; Joachim Ewald Kühn; Marc Tim Hennies; Marie-Luise Romberg; Marlin Maybrit Müller; Matthias Stelljes; Michael Schoefbaenker; Phil-Robin Tepasse; Richard Vollenberg; Rieke Neddermeyer; Stephan Ludwig; Theresa Günther
 
Oct 15, 2024
 
Prev Next